Show Notes: In this episode, I chat with Ben LeNail, Healthcare Investor & Consultant. Ben Lenail, based in Palo Alto CA, has consulted with biotech companies such as Minoryx Therapeutics, Autobahn Therapeutics, and Deep Genomics. Ben is an investor in 15 early-stage healthcare companies with HealthTech Capital. He is a mentor with the Chan Zuckerberg Initiative; and serves on the Board of ALD Connect and the Advisory Board of the UCSF Center for Vulnerable Populations. Ben has worked in high-tech in Silicon Valley for 30+ years. He’s a graduate of the University of Washington in Seattle WA and Sciences-Po in Paris. Ben’s wife Laurie Yoler has been his partner for three decades. Explore more! WSJ Profile: https://www.wsj.com/articles/a-rare-disease-wont-k… Mercury News Profile: https://www.mercurynews.com/2017/11/13/palo-alto-e… Brain & Life Profile: https://www.brainandlife.org/articles/adrenoleukod… See you all on Saturday! - Shivani Vyas ☺ @raredisorderpod on IG & Twitter, The Rare Disorder Podcast on LinkedIn https://linktr.ee/theraredisorderpodcast --- Support this podcast: https://anchor.fm/theraredisorderpodcast/support